Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

IDXX stock hub

IDXX trades against a final fair-value range of $231.99-$439.23, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

Read full analysis Valuation Archive

Fair value midpoint

$335

$232 - $439

Upside to midpoint

-37.2%

Based on latest report

Confidence

79/100

Data quality and model convergence

Market cap

$42.1B

NASDAQ

Our take

Research highlights

What our analysis says

Pulled from the latest published report. The full reasoning lives under /analysis.

Biggest opportunity

Bull case

Bull: Accelerating global pet humanization, increased diagnostic utilization per clinical visit, and ongoing margin expansion drive sustained double-digit earnings growth.

Biggest risk

Severe Valuation Compression

Recommended action

Sell

IDXX is rated Sell at $533.92 versus the reconciled fair value midpoint of $335.08, implying -37.24% upside/downside. Confidence is separately disclosed at 79/100.

Market data

Live price

Current market quote for this ticker.

Current price

IDXX

In the news

Latest news · IDXX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Analysis map

Jump into the research surface

These links all point into /analysis/*, so a hub rollback leaves the report reader and legacy redirects live.

Forecast

Targets

Bull, base, and bear cases with expected-return framing.

Valuation

Models

Fair-value bridge, DCF, owner earnings, and peer multiples.

Sensitivity

Grid

Cost-of-equity and terminal-growth stress table.

Risks

Bear case

Kill scenarios, soft-pass flags, and downside catalysts.

Earnings

Decision tree

Next earnings setup and beat / inline / miss thresholds.

Position sizing

Checkpoints

Entry, exit, conviction, and quarterly monitoring rules.

Financials

History

Revenue, margins, cash flow, and balance-sheet context.

Peers

Comps

Relative valuation and profitability against the cohort.

Moat

Durability

Economic-profit evidence and competitive advantage risk.

Industry cycle

Context

Sector phase, capital cycle, and secular tailwinds.

Scorecard

Factors

Six-factor overlay and 9-category weighted scorecard.

Recommendation

Verdict

Final action, action steps, opportunity, and biggest risk.

Perspectives

Lenses

Growth, value, and income investor reads.

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.4

P25 12.3P50 18.4P75 33.1

Trailing P/E0

P25 14.9P50 23.2P75 38.5

ROE72.9

P25 -105.6P50 -46.5P75 -3.1

ROIC46

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Our take

Indicator catalog

All IDXX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

270

Groups with data

Currency

USD

Showing 270 of 270 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000874716
Company name	IDEXX Laboratories, Inc.
Country	United States
Country code	US
Cusip	45168D104
Employees	11,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$45.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500, NASDAQ100
Industry	Diagnostics & Research
IPO Date	1991-06-21
Isin	US45168D1046
Last refreshed	2026-05-10
Market cap	$44.2B
Market cap category	Large-Cap
Price	$560
Price currency	USD
Rev Per Employee	404,190.45x
Sector	Healthcare
Sic	2835
Symbol	IDXX
Website	https://www.idexx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.48%
EV Earnings	41.17x
EV Sales Forward	9.29x
EV/EBIT	32.27x
EV/EBITDA	29.17x
EV/FCF	41.62x
EV/Sales	10.14x
FCF yield	2.45%
Forward P/E	37.22x
P/B ratio	28.52x
P/E ratio	41.2x
P/S ratio	9.94x
PE Ratio10 Y	53.41x
PE Ratio3 Y	46.67x
PE Ratio5 Y	51.78x
PEG ratio	2.99x
PS Forward	9.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.42%
EBITDA Margin	34.77%
FCF margin	24.37%
Gross margin	62.05%
Gross Profit	$2.8B
Gross Profit Growth	14.52%
Gross Profit Growth Q	15.94%
Gross Profit Growth3 Y	10.43%
Gross Profit Growth5 Y	10.4%
Net Income	$1.1B
Net Income Growth	22.38%
Net Income Growth Q	14.74%
Net Income Growth Quarters	7%
Net Income Growth Years	3%
Net Income Growth3 Y	16.14%
Net Income Growth5 Y	10.19%
Pretax Margin	30.8%
Profit Margin	24.63%
Profit Per Employee	$99,567
Profitable Years	27
ROA	26.46
Roa5y	23.48
ROCE	66.99
ROE	72.92
Roe5y	84.36
ROIC	45.95
Roic5y	45.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.53%
Cagr15y	19.12%
Cagr1y	15.12%
Cagr20y	18.21%
Cagr3y	4.67%
Cagr5y	0.58%
EPS Growth	25.7
EPS Growth Q	17.23
EPS Growth Quarters	7
EPS Growth Years	3
EPS Growth3 Y	17.86
EPS Growth5 Y	11.83
FCF Growth	27.81%
FCF Growth Q	12.66%
FCF Growth3 Y	33.47%
FCF Growth5 Y	10.21%
OCF Growth	24.96%
OCF Growth Q	11.89%
OCF Growth10 Y	16.71%
OCF Growth3 Y	25.5%
OCF Growth5 Y	10.2%
Revenue Growth	13.08x
Revenue Growth Q	14.26x
Revenue Growth Quarters	45x
Revenue Growth Years	28x
Revenue Growth3 Y	9.02x
Revenue Growth5 Y	9.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.35
Assets	$3.4B
Cash	$200.5M
Current Assets	$1.5B
Current Liabilities	$1.3B
Debt	$1.1B
Debt EBITDA	$0.7
Debt Equity	$0.71
Debt FCF	$1.02
Equity	$1.6B
Interest Coverage	35.89
Liabilities	$1.8B
Long Term Assets	$1.9B
Long Term Liabilities	$529.5M
Net Cash	$-904.9M
Net Cash By Market Cap	$-2.05
Net Debt EBITDA	$0.59
Net Debt Equity	$0.58
Net Debt FCF	$0.84
Tangible Book Value	$1B
Tangible Book Value Per Share	$13.12
WACC	12.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.12
Inventory Turnover	4.34
Net Working Capital	$660.5M
Quick ratio	0.69
Working Capital	$154.2M
Working Capital Turnover	$26.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.6%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	546.85%
1Y total return	15.1%
200-day SMA	642.3
3Y total return	14.66%
50-day SMA	581.7
50-day SMA vs 200-day SMA	50under200
5Y total return	2.91%
All Time High	770
All Time High Change	-27.26%
All Time High Date	2025-11-26
All Time Low	0.84
All Time Low Change	66,279.47%
All Time Low Date	1991-08-19
ATR	19.4
Beta	1.57
Beta1y	1.08
Beta2y	0.84
Ch YTD	-17.21
High	572.2
High52	770
High52 Date	2025-11-26
High52ch	-27.26%
Low	555.2
Low52	485.4
Low52 Date	2025-05-08
Low52ch	15.39%
Ma50ch	-3.72%
Price vs 200-day SMA	-12.79%
RSI	44.46
RSI Monthly	50.62
RSI Weekly	38.9
Sharpe ratio	0.43x
Sortino ratio	1.08
Total Return	2.6%
Tr YTD	-17.21
Tr15y	1,278.9%
Tr1m	-2.56%
Tr1w	-1.3%
Tr3m	-13.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	3
Analyst Price Target Top	$743
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$3.41
Earnings EPS Estimate Growth	18.82
Earnings Revenue Estimate	1,111,065,312x
Earnings Revenue Estimate Growth	11.28x
Operating Income	$1.4B
Operating Income Growth	14.85
Operating Income Growth Q	11.38
Operating Income Growth3 Y	14.49
Operating Income Growth5 Y	11.86
Operating margin	31.42
Price target	$722
Price Target Change	$28.84
Price Target Change Top	$32.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,012,659%
Float Percent	98.9%
Net Borrowing	32,115,000
Shares Insiders	0.99%
Shares Institutions	94.38%
Shares Out	78,882,997
Shares Qo Q	-0.4%
Shares Yo Y	-2.6%
Short Float	2.65%
Short Ratio	4.06
Short Shares	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1B
Average Volume	561,877.5x
Bv Per Share	19.64
CAPEX	$-126.6M
Ch10y	546.9
Ch15y	1,278.9
Ch1m	-2.56
Ch1w	-1.3
Ch1y	15.1
Ch20y	2,736
Ch3m	-13.11
Ch3y	14.66
Ch5y	2.91
Ch6m	-20.94
Change	-2.11%
Change From Open	-2.11
Close	572.2
Days Gap	0
Depreciation Amortization	148,803,000
Dollar Volume	266,964,109.1
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$1.4B
EBITDA	$1.5B
EPS	$13.59
F Score	7
FCF	$1.1B
FCF EV Yield	2.4x
FCF Per Share	$13.73
Financing CF	-1,046,073,000
Fiscal Year End	December
Founded	1,983
Goodwill	412,104,000
Graham Number	77.50207
Graham Upside	-86.16
Income Tax	$274.3M
Investing CF	-140,173,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2015-06-16
Last Split Type	Forward
Last10k Filing Date	2026-02-20
Lynch Fair Value	$139
Lynch Upside	-75.27
Ma150	645.9
Ma150ch	-13.29%
Ma20	570.9
Ma20ch	-1.89%
Net CF	36,558,000
Next Earnings Date	2026-08-03
Open	572.2
Optionable	Yes
P FCF Ratio	40.78
P OCF Ratio	36.51
Position In Range	28.92
Post Close	560.1
Postmarket Change Percent	-0.02
Postmarket Price	$560
Ppne	861,777,000
Price Date	2026-05-08
Price EBITDA	$28.58
Ptbv Ratio	42.51
Relative Volume	0.85x
Revenue	4,446,095,000x
SBC By Revenue	1.39x
Share Based Comp	61,738,000
Tax By Revenue	6.17x
Tax Rate	20.03%
Tr20y	2,736%
Tr6m	-20.94%
Us State	Maine
Volume	476,628
Z Score	21.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

9/10

Business quality stays separate from stock attractiveness.

Forward P/E

32.4x

Valuation uses the full report model stack, not a single multiple.

Next action

Sell

Final action steps are kept in the recommendation tab.

Our take

Income

Does IDXX pay a dividend?

Capital-return profile for this ticker.

Performance

IDXX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDXX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+94.4%

Float: +98.9% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IDXX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.5

Neutral momentum band

Price vs 200-day MA

-12.8%

50/200-day relationship not available

Beta (5Y)

1.57

More volatile than the market

Sharpe ratio

0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Peers

IDXX vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.3T	35.6x	9.5x	104.3%	+6.8%	+50.1%	بيع
ABNB	Airbnb Inc.	84B	34.7x	6.6x	15.9%	+29.9%	+14.9%	احتفاظ
ADBE	Adobe Inc.	102.3B	14.8x	4.2x	63.3%	+12.3%	-34.3%	شراء قوي

Questions

About IDXX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IDXX stock rating?

IDEXX Laboratories, Inc. is currently shown with Sell in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IDXX analysis?

The full report lives at /stocks/IDXX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IDXX?

The latest report frames IDXX around $232 to $439. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IDXX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.